DK1286674T3 - Sammensætning til forstærkning af cancerkemoterapeutiske midler - Google Patents

Sammensætning til forstærkning af cancerkemoterapeutiske midler

Info

Publication number
DK1286674T3
DK1286674T3 DK01964398T DK01964398T DK1286674T3 DK 1286674 T3 DK1286674 T3 DK 1286674T3 DK 01964398 T DK01964398 T DK 01964398T DK 01964398 T DK01964398 T DK 01964398T DK 1286674 T3 DK1286674 T3 DK 1286674T3
Authority
DK
Denmark
Prior art keywords
chemotherapeutic agents
composition
cancer chemotherapeutic
enhancing cancer
enhancing
Prior art date
Application number
DK01964398T
Other languages
English (en)
Inventor
Raxit J Jariwalla
Original Assignee
Ester C Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ester C Company filed Critical Ester C Company
Application granted granted Critical
Publication of DK1286674T3 publication Critical patent/DK1286674T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01964398T 2000-09-01 2001-08-24 Sammensætning til forstærkning af cancerkemoterapeutiske midler DK1286674T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/654,377 US6468980B1 (en) 2000-09-01 2000-09-01 Methods and compositions for potentiating cancer chemotherapeutic agents
PCT/US2001/026455 WO2002020023A1 (en) 2000-09-01 2001-08-24 Methods and compositions for potentiating cancer chemotherapeutic agents

Publications (1)

Publication Number Publication Date
DK1286674T3 true DK1286674T3 (da) 2008-11-03

Family

ID=24624611

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01964398T DK1286674T3 (da) 2000-09-01 2001-08-24 Sammensætning til forstærkning af cancerkemoterapeutiske midler

Country Status (15)

Country Link
US (1) US6468980B1 (da)
EP (1) EP1286674B1 (da)
JP (1) JP2004508335A (da)
KR (1) KR20030019297A (da)
AT (1) ATE400267T1 (da)
AU (1) AU8525401A (da)
CA (1) CA2389602A1 (da)
CY (1) CY1108787T1 (da)
DE (1) DE60134740D1 (da)
DK (1) DK1286674T3 (da)
ES (1) ES2309085T3 (da)
MX (1) MXPA02004327A (da)
PT (1) PT1286674E (da)
TR (1) TR200201192T1 (da)
WO (1) WO2002020023A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878744B2 (en) * 1999-02-05 2005-04-12 Oxycal Laboratories, Inc. Vitamin C compositions
CN1197561C (zh) * 2001-07-03 2005-04-20 北京巨能亚太生命科学研究中心 L－苏糖酸钙在制备预防或治疗损及软骨的疾病的药物中的用途
ATE444063T1 (de) 2003-08-13 2009-10-15 Ester C Company Verfahren zur linderung von umweltbedingtem stress durch oxidationsmittel und regulierung vorteilhafter gene
EP3542785A1 (en) * 2007-01-31 2019-09-25 Rutgers, The State University of New Jersey Controlled release of actives in skin
KR101998246B1 (ko) * 2018-08-22 2019-07-10 주식회사 메타파인즈 금속이온에 결합된 이온화합물을 포함하는 암 치료용 약학 조성물
TR2022000209A2 (tr) 2022-01-07 2022-02-21 Oezge Gueven Ozoni̇ze c-vi̇tami̇ni̇ i̇çeren bi̇r anti̇-kanser i̇laci

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003481A1 (en) * 1985-12-05 1987-06-18 American Biotechnology Co., Ltd. Anthracycline type antitumor agents with l-ascorbic acid
GB8810173D0 (en) * 1988-04-29 1988-06-02 Norsk Hydro As Pharmaceutical compositions with anti-cancer activity & method for treatment of cancer
WO1990012571A1 (en) * 1989-04-07 1990-11-01 Oxycal Laboratories, Inc. Compositions and methods for administering vitamin c
JPH08291075A (ja) * 1995-04-20 1996-11-05 Showa Denko Kk 癌転移阻害剤
EP0875246A1 (en) * 1997-04-04 1998-11-04 Showa Denko Kabushiki Kaisha Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer
ES2274618T3 (es) * 1998-02-06 2007-05-16 The Ester C Company Composiciones liquidas estables de ascorbato de calcio, y metodos de de preparacion y uso.
CN1165301C (zh) * 1999-08-30 2004-09-08 奥克斯可尔实验室公司 组合物在制备治疗癌症的药物中的用途

Also Published As

Publication number Publication date
US6468980B1 (en) 2002-10-22
EP1286674A4 (en) 2005-12-21
AU8525401A (en) 2002-03-22
CY1108787T1 (el) 2014-04-09
KR20030019297A (ko) 2003-03-06
DE60134740D1 (de) 2008-08-21
CA2389602A1 (en) 2002-03-14
ES2309085T3 (es) 2008-12-16
JP2004508335A (ja) 2004-03-18
EP1286674A1 (en) 2003-03-05
ATE400267T1 (de) 2008-07-15
PT1286674E (pt) 2008-08-21
EP1286674B1 (en) 2008-07-09
MXPA02004327A (es) 2002-11-07
WO2002020023A1 (en) 2002-03-14
TR200201192T1 (tr) 2003-05-21

Similar Documents

Publication Publication Date Title
TR200000782T2 (tr) Resorsinol türevleri.
BR0215405A (pt) Composições e processos de uso de collajolie
DK1311482T3 (da) Ikke-imidazolaryloxypiperidiner som H3-receptorligander
DE60106954D1 (de) Resorcin-derivate
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
DE602004012083D1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
MXPA04004347A (es) Nuevos fotoindicadores difuncionales.
BG106738A (en) A method for chemoprevention of prostate cancer
BR0209149A (pt) Ftalazinonas
CY1108787T1 (el) Συνθεση για ενισχυση χημειοθεραπευτικων παραγοντων καρκινου
TR200100455T2 (tr) Nimesulid içeren topikal farmasötik bileşimler
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
ATE248822T1 (de) Partikel mit kontrollierter freisetzungsrate
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
TR200102742T2 (tr) Rezorsinol türevleri
SE9903290D0 (sv) Novel compounds
ATE232081T1 (de) Orale zusammensetzung enthaltend perlit
TR200302193T4 (tr) Kombinasyon kemoterapisi.
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
DE60134814D1 (de) C10-carbamoyloxysubstituierte taxane als antitumormittel
ATE392422T1 (de) C7-carbamoyloxysubstituierte taxane als antitumormittel
BR0113202A (pt) Compostos de trioxepano
DK1521752T3 (da) Makrocykliske forbindelser til behandling af cancer
DE60220699D1 (de) Tibolonformulierungen
DE60213522D1 (de) Kombination von Arnica, Ruscus und Menthol